Immunoreactive with sera from Chlamydia trachomatis W4 infected individuals with minimum specificity problems.
Source
Recombinant protein corresponding to MOMP immunodominant region aa191-286 of Chlamydia trachomatis W4, fused to 6x-His at C-terminal, expressed in E. coli.
Applications
Suitable for use in ELISA, Western Blot, Flow-through. Other applications not tested.
Recommended Dilution
Optimal dilutions to be determined by the researcher.
Storage and Stability
Aliquot to avoid repeated freezing and thawing and store at -70°C. Aliquots are stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Source
Recombinant, E. coli
Form
Supplied as a liquid in 1.5M Urea, 20mM Tris-HCLl, pH 7.2, 50% glycerol.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.